Neovasc Operating Income

Neovasc (NVCN) currently reports a operating income of $-34M as of December 2022. That compares with $-31M in the prior-year period — down 8.7% year over year. Use the charts on this page to explore Neovasc's operating income history and peer comparisons.

Neovasc's operating income decreased from $-31M to $-34M — a 8.7% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Neovasc reported $-34M in operating income as of December 2022. That compares with $-31M in the prior-year period — down 8.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-34M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Neovasc, and consider following NVCN for alerts when major investors trade the stock.

Neovasc is classified in the Healthcare sector. On operating income, it currently shows $-34M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NVCN with unrelated industries.